Cancer Clinical Work
We are establsihing a comprehensive cancer development program to address all licensed cancer types. As on January 30, 2019 we are working on the following indications and their associated milestones:
Preclinical Phase I Pivotal Trial Approval - Glioblastoma - Prostate Cancer - Colon & Rectal Cancer - Non-Hodgkin Lymphoma - Endometrial Cancer - Stomach Cancer - Bladder Cancer - Cervical Cancer - Lung Cancer - Thyroid Cancer - Leukemia - Breast Cancer - Kidney Cancer - Ovarian Cancer - Liver Cancer - Myeloma - Lip-oral Cavity Cancer - Oesophagus Cancer - Brain Cancer - Gallbladder Cancer
The first two cancers to be addressed are Glioblastoma and Prostate Cancer. We anticipate initiating Phase I trials for both of these indications in Q3 of 2021.